Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccinations01:51

Vaccinations

53.4K
Overview
53.4K
Vaccine Production01:23

Vaccine Production

30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30
Vaccines01:21

Vaccines

25
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
25
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming vaccinology.

Cell·2024
Same author

Scientists' call to action: Microbes, planetary health, and the Sustainable Development Goals.

Cell·2024
Same author

Next generation of "magic bullets", solutions from the microbial pangenome.

EMBO molecular medicine·2024
Same author

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Cell reports·2024
Same author

Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight.

Vaccine·2024
Same author

SARS-CoV-2 JN.1 variant evasion of IGHV3-53/3-66 B cell germlines.

Science immunology·2024
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

Future Challenges for Vaccinologists.

Sunil Thomas1, Rima Dilbarova2,3, Rino Rappuoli4

  • 1Lankenau Institute for Medical Research, 100 East Lancaster Avenue, Wynnewood, PA, 19096, USA. thomass-02@mlhs.org.

Methods in Molecular Biology (Clifton, N.J.)
|April 15, 2016
PubMed
Summary
This summary is machine-generated.

Vaccines have saved countless lives and boosted agriculture, yet many diseases like cancer and malaria lack effective vaccines. Innovative strategies are crucial for developing new vaccines against emerging threats and antibiotic-resistant bacteria.

Keywords:
Antibiotic resistanceClimate changeInfectious diseaseStructure-based vaccineVaccine

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K

Area of Science:

  • Immunology
  • Public Health
  • Veterinary Medicine

Background:

  • Vaccination is a highly cost-effective healthcare intervention, significantly reducing the incidence of infectious diseases and improving quality of life.
  • Successful immunization programs have led to the eradication of diseases like smallpox and polio, and improved agricultural output.
  • Despite successes, numerous diseases, including cancers, autoimmune disorders, and infectious diseases like tuberculosis and malaria, remain without effective vaccines.

Purpose of the Study:

  • To highlight the successes and limitations of current vaccination programs.
  • To identify critical areas where novel vaccine development is urgently needed.
  • To emphasize the necessity of innovative strategies for future vaccine design.

Main Methods:

  • Review of historical vaccination successes and current disease burdens.
  • Analysis of challenges in developing vaccines for non-communicable and infectious diseases.
  • Discussion of emerging threats, including antibiotic resistance and climate change impacts.

Main Results:

  • Vaccination has dramatically reduced mortality and morbidity from many infectious diseases.
  • Significant gaps exist in vaccine availability for major global health challenges.
  • Antibiotic resistance and climate change pose new challenges requiring novel vaccine approaches.

Conclusions:

  • Innovative vaccination strategies are essential to address unmet medical needs and emerging health threats.
  • Development of new vaccines is critical for combating antibiotic-resistant microorganisms.
  • Future vaccine research must adapt to evolving global health landscapes, including climate change impacts.